Taylor & Francis Group

Future Science Group

Podcast by Taylor & Francis Group

Mindenképp látogasd meg a podcast oldalát, és támogasd a készítőjét: soundcloud.com

Szerző

Taylor & Francis Group

Kategória

Science

A podcast weboldala

soundcloud.com

Legutóbbi epizód

2026. okt. 8.

Hol hallgathatod?

Podcastok az alkalmazásban Replaio Radio Hamarosan

A podcastok hamarosan megérkeznek az alkalmazásba. Telepítsd most, és láss elsőként egy teljesen új megközelítést a podcastokhoz

Letöltés a Google Play-ről Telepítsd ingyen Android közel 10 M letöltés · 4,8-as értékelés iOS hamarosan

Epizódok

NCTalks with Wendy Weidner: the global situation of dementia 11.06.2018

Whilst at the Alzheimer’s Society Annual Conference (22–23 May, London, UK), we had the pleasure of speaking to Wendy Weidner, the Research and Policy Project Lead for Alzheimer’s Disease International, to hear more about her talk on ‘A world without dementia’. In this #NCTalks podcast recorded at the event, Sharon Salt (Editor) speaks to Wendy to find out more about the work that Alzheimer’s Dise...

TalkingTechniques with Irina Armean: Combining proteomics and machine learning 06.06.2018

Irina Armean from the European Bioinformatics Institute discusses the gene ontology (GO) and how machine learning can play a role in evaluating protein protein interactions (PPIs).

NCTalks with Simon Lovestone: an insight into big data and dementia 05.06.2018

Whilst at the Alzheimer’s Society Annual Conference (22–23 May, London, UK), we had the pleasure of speaking to Simon Lovestone, a Professor of Translational Neuroscience at the University of Oxford (UK), to hear more about his talk on ‘Dementia – Big problem; Big Data – Big solution?’ In this #NCTalks podcast recorded at the event, Sharon Salt (Editor) speaks to Simon to find out more about big d...

NCTalks with Aleksandar Videnovic: what does a career in clinical trials involve? 31.05.2018

At the American Academy of Neurology’s 70th Annual Meeting (21–27 April, CA, USA), we spoke to Aleksandar Videnovic, a neurologist at Massachusetts General Hospital (MA, USA), about what a career in clinical trials involves. Aleksandar is also an Associate Professor of Neurology at Harvard Medical School (MA, USA). In this #NCTalks podcast recorded at the event, Lauren Pulling (Publisher) speaks t...

NCTalks with Jens Kuhle: monitoring multiple sclerosis using blood neurofilament light protein 22.05.2018

In this latest edition of NCTalks, Sharon Salt (Editor) speaks with Jens Kuhle, a neurologist at the University Hospital Basel, Switzerland. Jens is the head of the multiple sclerosis (MS) center at the hospital and runs a research group called ‘Translational Biomarkers and Biobanking’. In this podcast, Jens speaks about monitoring MS using blood neurofilament light protein and how this could impa...

NCTalks with Giovanni Baranello: spinal muscular atrophy and the FIREFISH trial 17.05.2018

In this latest edition of NCTalks, Lauren Pulling (Publisher) speaks to Giovanni Baranello, a Pediatric Neurologist working at the Carlo Besta Neurological Institute (Milan, Italy). Giovanni is the principal investigator of the FIREFISH clinical trial, a preliminary study investigating the safety and efficacy of RO7034067 in infants with type 1 spinal muscular atrophy. In this podcast recorded at...

Chromatographic method development, top tips and future hopes: an interview with Cory Muraco 10.05.2018

As part of our Spotlight, we present this interview with Cory Muraco who discusses his interest in chromatography, the technologies he uses and his top three tips for chromatographic method development.

Addressing the key challenges and questions when deciding between old vs new technologies 09.05.2018

As part of our focus, In the Zone: old vs new technologies, we present this podcast where we talk to Franklin Spriggs (Director of Large Molecule Services, KCAS) about his experience with investing in different technologies, and the key questions that need to be addressed when making any decision between different technologies. To find out more, visit: http://bit.ly/2rwG1fZ

NCTalks with Robert Fox: current landscape and potential treatment regimens for ibudilast in MS 04.05.2018

Last week we had the pleasure of attending the American Academy of Neurology’s 70th Annual Meeting (April 21–27, CA, USA), where we spoke to Robert Fox, from the Mellen Center for Multiple Sclerosis at the Cleveland Clinic (OH, USA), about the Phase II SPRINT-MS trial of ibudilast in progressive multiple sclerosis. In this #NCTalks podcast recorded at the event, Lauren Pulling (Publisher) speaks t...

NCTalks with Giovanna Mallucci: the UK DRI, promising dementia research and future outlook 01.05.2018

Whilst at the Alzheimer’s Research UK (ARUK) Conference (20–21 March, London, UK), Lauren Pulling (Publisher) spoke to Giovanna Malluci, a Professor of Clinical Neurosciences at the University of Cambridge (UK) and Consultant Neurologist specializing in dementia. Giovanna is also the Associate Director of the Cambridge Center of the UK Dementia Research Institute (DRI). In this #NCTalks podcast re...

Scaling up cell therapy manufacture: an interview with Ankita Desai, Eppendorf AG 01.05.2018

In this podcast, Eppendorf Bioprocess Field Application Specialist Ankita Desai discusses the challenges of scaling up a cell therapy.

NCTalks with Alexander Rae-Grant: a new guideline for multiple sclerosis treatment 24.04.2018

This week we had the pleasure of attending the American Academy of Neurology’s 70th Annual Meeting (April 21–27, CA, USA), where we spoke to Alexander Rae-Grant, from the Cleveland Clinic Lerner Medical School (OH, USA), about the new guideline for multiple sclerosis treatment. Alexander is the lead author of the multiple sclerosis guideline for the American Academy of Neurology. In this #NCTalks...

NCTalks with Tara Spires-Jones: ApoE4, synapse degeneration and Alzheimer’s 09.04.2018

In this latest edition of NCTalks, Lauren Pulling (Editor) chats with Tara Spires-Jones, a Professor of Neurodegeneration at the University of Edinburgh (UK). Tara is Deputy Director of the Centre for Discovery Brain Sciences and Program Lead at the Edinburgh center of the UK Dementia Research Institute. Tara is also Chair of the Alzheimer’s Research UK (ARUK) Grant Review Board, and is active is...

The Microbe Directory – an interview with Heba Shaaban and David Westfall 27.02.2018

The Microbe Directory is a collective research effort aiming to profile over 7,000 microbes in order to provide further information for any researchers carrying out metagenomic analyses. We spoke to two of the Project Leaders, Heba Shaaban and David Westfall about the project, how it’s being used in research and how you can get involved.

Tuberculosis and diagnosis – the week in infectious diseases 23.02.2018

Listen to the top stories in infectious diseases this week, including novel CRISPR-based diagnostics, clinical trial in tuberculosis and the latest CDC approvals for the flu vaccine. Find the full stories: https://www.id-hub.com

Measles vaccine and Zika– the week in infectious diseases 16.02.2018

Take a look at the top news stories of the week, including the measles vaccine and the sexual transmission of Zika.

What new technology would you like to see? 15.02.2018

In the final part of this 3-part panel discussion, our experts talk through the recent changes in the type of molecules and technologies the field are working with and what new technologies need to emerge to overcome current problems.

New regulations – what are your hopes? 15.02.2018

In part 2 of this 3-part panel discussion our panelists discuss the exciting topic of regulations as they consider the ICH M10 guidance and where they think the field might be going in the future.

Outsourcing do we all have the right priorities when making a purchasing decision? 15.02.2018

In part 1 of this 3-part panel discussion highlight filmed in Barcelona our panel of experts discuss the issue of outsourcing and what priorities are need considering when making a purchasing

The facts, frustrations and future hopes for immuno-oncology: a podcast with Dr Dominic Warrino 14.02.2018

As part of our focus, we present this podcast where Dr Dominic Warrino discusses how immuno-oncology fits into the bioanalytical field and the technologies involved.

#OCTalks rectal cancer: top down, bottom up, robotic, laparoscopic or open with David Jayne 06.12.2017

In this interview Roshaine Wijayatunga (Senior Editor: Oncology) speaks with David Jayne about colorectal surgery in regards to the development, application and evaluation of new surgical technologies.

#OCTalks the future of breast cancer research with Matthew Ellis 05.12.2017

In this interview Roshaine Wijayatunga (Senior Editor: Oncology) speaks with Matthew Ellis at the 2017 NCRI Cancer Conference 5–8 Nov 2017 about the future of proteomics and breast cancer research.

#OCTalks breast surgery and reconstruction with Michael Douek 28.11.2017

In this interview Roshaine Wijayatunga (Senior Editor: Oncology) speaks with Michael Douek at the 2017 NCRI Cancer Conference 5–8 Nov 2017 about novel techniques for breast surgery and reconstruction.

IDHTalks: Developing trispecific antibodies against HIV – an interview with Richard Koup 27.11.2017

In this World AIDS Day interview we speak to Richard Koup, who was recently an author on a study reporting a trispecific antibody able to target 99% of HIV strains. www.id-hub.com

NCTalks at SfN17: Nicole Swann on adaptive DBS and Parkinson’s disease 22.11.2017

One of the major themes from this year’s SfN Neuroscience meeting (Washington DC, USA, 11–15 November 2017) was developments in neuromodulation techniques, including deep brain stimulation (DBS) and transcranial magnetic stimulation (TMS). One study highlighted by the society came from Nicole Swann (University of California, San Francisco, LA, USA) and colleagues, who presented evidence that a nov...

Hallgasd a(z) Future Science Group podcastot a Replaióban

Rádió és podcastok egy alkalmazásban - ingyen és regisztráció nélkül. Telepítsd még ma, és ne maradj le a premierről

Letöltés a Google Play-ről

A Replaio nem podcastkiadó; a műsorok nevei, borítóképei és hanganyagai a szerzőiket illetik, és nyilvános RSS-csatornákon keresztül terjednek.